News

In the U.S., the designation carries significant incentives for the development of drugs to treat rare and difficult diseases. The Company is preparing to commence a Phase 2

Originated from the labs of David Baltimore, Nobel Laureate and President Emeritus, and Robert Andrews, Millikan Professor of Biology at Caltech, the technology uses the patient’s own hematopoietic

MM-398 is an investigational drug candidate designed to increase drug deposition and prolong cytotoxic effects, with the goal of improving its anti-cancer properties. Currently, Merrimack is preparing a

Under the deal, Sothema will be responsible for marketing and selling Zestra and its high viscosity water-based lubricant Zestra Glide in Middle East (Excluding Lebanon and Israel), North

More than 10,000 mosquitoes infected with bacteria that suppress dengue fever have been released by scientists at the Rio de Janeiro-based Fiocruz research institute to let them multiply

Currently, the company is enrolling cancer patients in a Phase Ib clinical trial and expects to complete the trial in the first quarter of 2015. In preclinical trials,

Overall, the study demonstrated positive results with respect to the trial’s primary efficacy endpoint with no serious adverse events. Lipocine continues to expect to file a New Drug

In addition to this recently allowed application, the patent family includes applications pending in other major markets including Australia, Canada, China, Europe and Japan. The exclusively licensed technology

This grant was made by the National Institute of Environmental Health Sciences to create a novel method for extracting molecular information from archived tissues. FFPE sample archives contain